Related Experiment Video
Updated: Aug 16, 2025

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
N6-methyladenosine Modification of Noncoding RNAs: Mechanisms and Clinical Applications in Cancer
Mingyang Ma1, Tong Ye1, Jiewei Wang1
1Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Abstract:
N6-methyladenosine (m6A) modification remains the most pivotal epigenetic modification on RNA. As we know, m6A not only affects physiological processes but is also involved in carcinoma. Noncoding RNAs play an indispensable role in the occurrence and development of carcinoma. However, a large amount of research is focused on mRNA currently. Insufficient research has been done on the relationship between noncoding RNA (ncRNA) methylation and cancer. Therefore, this review aims to introduce the theoretical knowledge of m6A modification in noncoding RNA, discuss its function in tumorigenesis and progression, and ultimately summarize its potential clinical applications.
Insights
N6-methyladenosine (m6A) modification is crucial in RNA epigenetics and cancer. This review explores m6A in noncoding RNAs, its role in tumorigenesis, and potential clinical applications for cancer treatment.
Area of Science:
- Epigenetics
- Molecular Biology
- Oncology
Background:
- N6-methyladenosine (m6A) is a key RNA epigenetic modification.
- m6A influences physiological processes and is implicated in carcinoma.
- Noncoding RNAs (ncRNAs) are vital in cancer development, yet their m6A methylation is understudied.
Purpose of the Study:
- To review the fundamental knowledge of m6A modification in ncRNAs.
- To discuss the role of ncRNA m6A methylation in cancer initiation and progression.
- To summarize the potential clinical applications of ncRNA m6A methylation in oncology.
Main Methods:
- Literature review
- Synthesis of existing research on m6A modification in ncRNAs
- Analysis of ncRNA methylation's role in tumorigenesis
Main Results:
- m6A modification is prevalent in various ncRNAs.
- Aberrant ncRNA m6A methylation is linked to multiple cancer hallmarks.
- Specific ncRNA methylation patterns may serve as cancer biomarkers.
Conclusions:
- m6A modification of ncRNAs is a significant factor in cancer.
- Understanding ncRNA m6A methylation offers novel therapeutic and diagnostic strategies.
- Further research into ncRNA m6A is essential for advancing cancer treatment.
Related Concept Videos
RNA Editing
MicroRNAs
RNA Stability
Nuclear Export of mRNA
Epigenetic Regulation
X-chromosome...
Pre-mRNA Processing: Modification of pre-mRNA Ends
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...

